Health and Medicine
Featured This Month
Steve Hickman, Psy.D., Executive Director of the UC San Diego Center for Mindfulness joins William Mobley, MD, PhD for a discussion of how to be present in the moment and leverage the practice of mindfulness to stay engaged, focused, and fulfilled.
What Is The Evidence That Food Addiction Exists? - 2016 COAST/SSEW Symposium - Food & Addiction: Environment, Policy, and Individual Factors
Ashley Gearhardt developed the Yale Food Addiction Scale (YFAS) to operationalize addictive-like eating behaviors, which has recently been linked with more frequent binge eating episodes in clinical populations, increased prevalence of obesity and patterns of neural activation implicated in other addictive behaviors. Recorded on 10/27/2016.
Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care.
Chris Freise, MD. Transplant surgeon, UCSF.
What’s Hot and What’s New in Transplantation - UCSF Kidney Transplant Program Update in Transplantation 2017
Sandy Feng, MD, PhD. Organ Transplant Surgeon, UCSF. Recorded on 05/19/2017.
Patients are frequently given the wrong antibiotics to treat bacterial infections, but it is not the physician who is at fault. The standard antibiotic test used worldwide is flawed since it is based on how well drugs kill bacteria on petri plates not how well they kill bacteria in the body. Mike Mahan describes an "in vivo" antibiotic test that mimics conditions in the body. Drugs that pass the standard test often fail to treat bacterial infections, whereas drugs identified by the test are very effective. Recorded on 07/24/2017.
Innovation In Science and Medicine: Potential Implications for Health Policy? - The Chancellor’s Health Policy Lecture Series
Dr. Hal Barron discusses what he has learned about innovation in science and medicine based on his over 20 years of experience in the biotechnology industry, and potential implications for health policy at the local, national and global level. Barron is one of the most respected clinician-scientists and successful drug developers in the biotechnology industry and serves as Calico's president of research and development. Recorded on 04.26.2017.
Discover the latest tools used to diagnose and treat back and neck pain.